ONESOURCE SPECL PHARMA L (ONESOURCE): ONESOURCE Share Price falls 5.51%: What is driving the decline?
- October 1, 2026
- Posted by: Kunal Singla
- Category: News
ONESOURCE Share Price is under pressure today, with the stock last traded at Rs 1,441.4 after falling 5.51%. The move came against a market capitalisation of Rs 18,168.92 crore, keeping ONESOURCE in the Mid Cap category. According to latest Univest data, the decline is confirmed, but no company-specific catalyst is established. That makes ONESOURCE Share Price important for investors who are tracking today’s price action, valuation context and pharma-sector positioning rather than a single event trigger. In ONESOURCE Stock News, the move stands out because the stock opened near the previous close but moved lower through the day’s range, making the ONESOURCE Share Price update a useful case study in intraday price fall analysis.
For readers tracking ONESOURCE Share Price Today, the key question is whether the move changes the way investors view ONESOURCE Share Price News. The answer lies in the verified numbers: price action, valuation, profitability ratios and comparisons with listed peers in the same industry.
ONESOURCE SPECL PHARMA L (ONESOURCE) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,441.4 |
| Previous Close | Rs 1,525.45 |
| Today's Move | -Rs 84.05 (-5.51%) |
| Open | Rs 1,515 |
| High | Rs 1,516.6 |
| Low | Rs 1,437.55 |
| Market Capitalisation | Rs 18,168.92 crore |
| Market Cap Category | Mid Cap |
ONESOURCE Share Price Today shows a clear intraday decline from the previous close of Rs 1,525.45 to Rs 1,441.4, a fall of Rs 84.05 or 5.51%. The stock opened at Rs 1,515 and touched a high of Rs 1,516.6 before moving to a low of Rs 1,437.55. That places the current trade close to the lower end of the day’s range, which is useful context for ONESOURCE Share Price tracking without adding any unsupported explanation.
The move is meaningful because it came in a Mid Cap company with a market capitalisation of Rs 18,168.92 crore. For ONESOURCE Share Price, the combination of a sharp day change and a wide spread between the open and low keeps the stock firmly in focus in ONESOURCE Stock News and ONESOURCE Share Price Fall coverage. As of 01 October 2026 at 1:23:21 PM IST, the price event is confirmed. The next layer of analysis is fundamentals, which helps separate today’s market move from the company’s longer-term financial profile.
ONESOURCE SPECL PHARMA L (ONESOURCE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 18,168.92 crore |
| P/B Ratio | 2.99x |
| ROE | -1.26% |
| ROCE | 0.44% |
| EPS | Rs -4.24 |
| Book Value Per Share | Rs 510.17 |
| Dividend Yield | 0% |
ONESOURCE SPECL PHARMA L (ONESOURCE) fundamental metrics show P/B 2.99x, ROE -1.26%, ROCE 0.44%. Taken on their own, these numbers offer context rather than a trading signal.
ONESOURCE SPECL PHARMA L has a market capitalisation of Rs 18,168.92 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 2.99x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -1.26% and ROCE of 0.44%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -4.24, book value per share of Rs 510.17, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.02x, median ROE of 11.7%, median ROCE of 13.61%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Benchmark Median P/E | 32.02x |
| Benchmark Average P/E | 49.17x |
| Benchmark P/E Range | 3.4x to 688.17x |
| Company P/B Ratio | 2.99x |
| Benchmark Median P/B | 2.94x |
| Benchmark Average P/B | 4.37x |
| Company ROE | -1.26% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 0.44% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 18,168.92 crore |
| Benchmark Median Market Cap | Rs 770.9 crore |
| Benchmark Average Market Cap | Rs 14,358.25 crore |
ONESOURCE SPECL PHARMA L (ONESOURCE) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
ONESOURCE SPECL PHARMA L (ONESOURCE) has a ROE of -1.26%, which is below the benchmark median of 11.7%, a difference of -110.77%. ONESOURCE SPECL PHARMA L (ONESOURCE) has a ROCE of 0.44%, which is below the benchmark median of 13.61%, a difference of -96.77%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,46,276.3 | 36.1 | 5.05 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,51,531.48 | 84.24 | 13.95 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,86,956.51 | 83.74 | 20.35 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,19,221.66 | 25.71 | 4.3 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,11,728.51 | 32.36 | 3.1 | 11.83 | 16 |
Its ROE of -1.26% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 0.44% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. ONESOURCE SPECL PHARMA L (ONESOURCE) has a market capitalisation of Rs 18,168.92 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching ONESOURCE
- ONESOURCE Share Price fell 5.51%, so the intraday move is large enough to keep ONESOURCE Stock News in focus.
- The stock is trading in the Mid Cap category with a market capitalisation of Rs 18,168.92 crore.
- ONESOURCE Share Price sits near book value context that is defined by Rs 510.17 per share.
- Negative EPS of Rs -4.24 and ROE of -1.26% make the fundamental backdrop important for ONESOURCE Share Price analysis.
- In the same industry, the company’s P/B is near the benchmark median, while return ratios trail the peer group.
About ONESOURCE
ONESOURCE SPECL PHARMA L operates in Healthcare and the Pharmaceuticals & Drugs industry. The company’s verified market position can be understood through its market capitalisation, return ratios and book value rather than through broad claims. For ONESOURCE Share Price readers, the business sits in a competitive pharma landscape where valuations often reflect earnings quality, return ratios and industry execution.
ONESOURCE Share Price therefore needs to be viewed in the context of the company’s negative EPS, low ROE and low ROCE, along with its P/B and book value. That combination gives investors a factual way to read ONESOURCE Stock News without relying on speculation. Univest data shows the company as a Mid Cap pharma name with material size in its industry and a performance profile that differs from higher-return peers.
Track ONESOURCE Share Price on Univest
Use ONESOURCE SPECL PHARMA L (ONESOURCE) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Investors tracking ONESOURCE Share Price can follow live price movement, valuation ratios, 52-week levels and market insights on Univest. The platform keeps ONESOURCE Share Price Today, ONESOURCE Fundamental Analysis and ONESOURCE Stock Analysis together in one place, which makes it easier to review the latest move alongside sector and peer context.
For readers who want ONESOURCE Share Price News in a compact format, Univest also helps compare the stock with its industry benchmark and listed peers. That makes the ONESOURCE Share Price update easier to interpret as market data changes through the day.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is ONESOURCE Share Price falling today?
Ans. ONESOURCE Share Price is lower by 5.51% today, with the stock last traded at Rs 1,441.4. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established.
What is ONESOURCE Share Price today?
Ans. ONESOURCE Share Price today is Rs 1,441.4. It is below the previous close of Rs 1,525.45 and has moved within a range from Rs 1,437.55 to Rs 1,516.6 so far.
How much did ONESOURCE Share Price decline?
Ans. ONESOURCE Share Price declined by Rs 84.05, or 5.51%, from the previous close. The move is notable because it came during the trading session and not at the session end.
What is the market capitalisation of ONESOURCE?
Ans. ONESOURCE has a market capitalisation of Rs 18,168.92 crore. That places the company in the Mid Cap category and above the same-industry market-cap median of Rs 770.9 crore. The company operates in the Healthcare sector.
What does ONESOURCE Fundamental Analysis show?
Ans. ONESOURCE Fundamental Analysis shows a P/B of 2.99, EPS of Rs -4.24, ROE of -1.26%, ROCE of 0.44% and book value of Rs 510.17 per share. Dividend yield is 0.
How does ONESOURCE compare with pharma peers?
Ans. ONESOURCE Share Price is being compared with larger pharma names such as Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. Its P/B is near Cipla but its return ratios trail the peer set.
Is ONESOURCE Share Price expensive or low-valued versus the industry?
Ans. ONESOURCE’s P/B of 2.99 is close to the industry median of 2.94 and below the industry average of 4.37. On return metrics, its ROE and ROCE are below benchmark medians.
What should investors monitor in ONESOURCE Share Price next?
Ans. Investors tracking ONESOURCE Share Price should watch whether the stock holds near the day’s low, how the valuation compares with the industry benchmark and whether future financial updates improve EPS, ROE or ROCE.
